Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database.
Authors
Lauren E. Schleimer
Memorial Sloan Kettering Cancer Center, New York, NY
Lauren E. Schleimer , Hannah L Kalvin , T. Peter Kingham , Kevin Soares , Michael Ian D'Angelica , Vinod P. Balachandran , Jeffrey A. Drebin , Andrea Cercek , Ghassan K. Abou-Alfa , Eileen Mary O'Reilly , James J. Harding , Mithat Gonen , Alice Chia-Chi Wei , William R. Jarnagin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Quality of Care/Quality Improvement
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 464)
DOI
10.1200/JCO.2024.42.3_suppl.464
Abstract #
464
Poster Bd #
B9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Downstaging locally advanced hepatocellular carcinoma with selective internal radiation therapy.
First Author: Marjorie Hoang
Poster
2022 ASCO Gastrointestinal Cancers Symposium
“Super massive” intrahepatic cholangiocarcinoma: Potential role of radiation therapy.
First Author: Joseph Abi Jaoude
Poster
2019 Gastrointestinal Cancers Symposium
Hypofractionated radiation therapy for unresectable/locally recurrent intrahepatic cholangiocarcinoma.
First Author: Alicia Smart
Poster
2018 ASCO Annual Meeting
A bi-institutional phase II study of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (Dex) combined with systemic gemcitabine and oxaliplatin (GemOx) for unresectable intrahepatic cholangiocarcinoma (ICC).
First Author: Andrea Cercek